RCG
AZN icon

Resource Consulting Group’s AstraZeneca AZN Stock Holding History

Resource Consulting Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$428K Buy
+3,175
New +$413K 0.07% 43
2023
Q3 		– Sell
-3,175
Closed -$454K – 54
2023
Q2 		$454K Buy
+3,175
New +$467K 0.09% 47
2022
Q4 		– Sell
-3,758
Closed -$412K – 37
2022
Q3 		$412K Buy
+3,758
New +$477K 0.12% 28

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Resource Consulting Group's AZN Position: Q4 2023 in Review

Resource Consulting Group opened a new position in AstraZeneca (AZN) in Q4 2023: 3,175 shares worth $428K. The stake represents 0.07% of the portfolio and ranks #43 among its holdings. This is a return to the name: Resource Consulting Group previously reported a position in AZN as recently as Q2 2023.

Resource Consulting Group first reported a position in AZN in Q3 2022 and has held it in 3 quarters since. The position peaked at $454K in Q2 2023. 1,130 funds tracked by Wall St. Rank hold AZN as of Q4 2023.

  • Resource Consulting Group held 3,175 shares of AstraZeneca worth $428K as of Q4 2023.
  • AstraZeneca was a new Resource Consulting Group position in Q4 2023.
  • AstraZeneca made up 0.07% of Resource Consulting Group's portfolio in Q4 2023, its #43 holding.
  • Resource Consulting Group first reported a position in AstraZeneca in Q3 2022 and has held it in 3 quarters since.
  • Resource Consulting Group's AstraZeneca position peaked at $454K in Q2 2023.
  • 1,130 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2023.

Based on Resource Consulting Group's 13F filing for Q4 2023, filed 11 Jan 2024.